CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR2 | Chemokine (C-C motif) receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR3 | Chemokine (C-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CCR4 | Chemokine (C-C motif) receptor 4 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CDS2 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CELSR3 | Cadherin, EGF LAG seven-pass G-type receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
CERS4 | Ceramide synthase 4 | Predicted membrane proteins
| | | | | Expressed in all |
CERS5 | Ceramide synthase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CERS6 | Ceramide synthase 6 | Predicted membrane proteins
| | | | | Expressed in all |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CMKLR1 | Chemokine-like receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
COQ2 | Coenzyme Q2 4-hydroxybenzoate polyprenyltransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
COX10 | Cytochrome c oxidase assembly homolog 10 (yeast) | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
COX15 | Cytochrome c oxidase assembly homolog 15 (yeast) | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CRHR2 | Corticotropin releasing hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CYBB | Cytochrome b-245, beta polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYSLTR1 | Cysteinyl leukotriene receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DARC | Duffy blood group, atypical chemokine receptor | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
DCST1 | DC-STAMP domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
DPY19L3 | Dpy-19-like 3 (C. elegans) | Predicted membrane proteins
| | | | | Mixed |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
DUOX1 | Dual oxidase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |